Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,983	4,704	1,636	2,937	1,622	2,340
Short-Term Investments	20,000	26,000	13,500	7,000	6,500	5,000
Cash & Short-Term Investments	28,983	30,704	15,136	9,937	8,122	7,340
Cash Growth	66.64%	102.86%	52.32%	22.34%	10.66%	59.17%
Accounts Receivable	4,892	5,182	6,575	5,596	3,013	3,232
Other Receivables	360.53	480.95	230.7	102.73	1.39	-
Receivables	5,333	5,743	6,806	5,699	3,014	3,232
Inventory	3,062	3,151	2,493	2,163	1,939	1,739
Prepaid Expenses	14.71	16.67	8.53	8.75	10.66	21.44
Other Current Assets	90	24.61	36.15	142.14	47.95	20.87
Total Current Assets	37,482	39,640	24,480	17,950	13,134	12,354
Property, Plant & Equipment	8,897	8,881	8,917	9,705	10,207	11,113
Long-Term Investments	-	-	-	1,969	3,384	2,827
Other Intangible Assets	151.6	173	51.54	-0	-0	152.29
Long-Term Deferred Tax Assets	160.17	162.43	207.95	493.84	-	42.96
Long-Term Deferred Charges	99.54	115.26	146.69	157.17	151.67	-
Other Long-Term Assets	3,196	188.95	167.01	193.54	90.16	108.14
Total Assets	49,986	49,161	33,970	30,469	26,967	26,598
Accounts Payable	1,724	1,543	2,266	2,220	1,249	1,302
Accrued Expenses	453	68.3	73.61	75.04	45.56	36.87
Short-Term Debt	6,360	6,000	6,000	6,000	7,000	7,000
Current Portion of Long-Term Debt	475	775	200	-	-	-
Current Portion of Leases	46.03	79.16	75.74	102.2	49.82	34.33
Current Income Taxes Payable	135.84	1,078	273.57	411.92	408.58	143.76
Other Current Liabilities	929.63	974.03	1,176	1,021	832.78	731.05
Total Current Liabilities	10,124	10,517	10,065	9,830	9,585	9,248
Long-Term Debt	-	-	775	675	-	-
Long-Term Leases	53.41	72.04	94.7	173.89	90.34	24.13
Long-Term Deferred Tax Liabilities	-	-	-	-	23.19	-
Other Long-Term Liabilities	79.09	67.03	55.05	59.91	31.22	0
Total Liabilities	10,256	10,656	11,025	12,160	10,824	10,259
Common Stock	553	553	500	500	500	500
Additional Paid-In Capital	9,970	9,970	-	-	-	-
Retained Earnings	30,519	29,294	25,736	21,260	17,804	15,741
Treasury Stock	-881.35	-881.35	-2,706	-2,706	-2,706	-
Comprehensive Income & Other	-431.07	-431.07	-584.88	-745.34	544.66	97.48
Shareholders' Equity	39,730	38,504	22,945	18,308	16,143	16,339
Total Liabilities & Equity	49,986	49,161	33,970	30,469	26,967	26,598
Total Debt	6,934	6,926	7,145	6,951	7,140	7,058
Net Cash (Debt)	22,048	23,778	7,991	2,986	982.27	281.25
Net Cash Growth	114.63%	197.58%	167.60%	203.99%	249.25%	-
Net Cash Per Share	4286.45	5135.70	1876.65	700.79	10630.51	2812.57
Filing Date Shares Outstanding	5.29	5.29	4.26	4.26	0.09	0.1
Total Common Shares Outstanding	5.29	5.29	4.26	4.26	0.09	0.1
Working Capital	27,358	29,123	14,414	8,120	3,549	3,106
Book Value Per Share	7512.45	7280.75	5388.68	4296.83	174704.28	163392.49
Tangible Book Value	39,578	38,331	22,893	18,308	16,143	16,187
Tangible Book Value Per Share	7483.79	7248.04	5376.58	4296.83	174704.29	161869.60
Land	1,817	2,020	2,020	2,020	2,020	2,020
Buildings	6,670	7,420	7,531	7,531	7,531	7,531
Machinery	7,874	9,114	8,599	8,457	8,088	7,662
Construction In Progress	734.89	231.19	190.08	127.21	-	260.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.